Log inSign up

Atalanta Therapeutics

1 follower

‌

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Industries

Biotechnology, Education

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Alicia Secor
President & CEO

Alicia Secor

Collapse
Aimee L. Jackson
Chief Scientific Officer
Morgan Molloy
Chief Corporate Development Officer
Bart G. Newland
General Counsel
Michele Keough
SVP, Program & Alliance Management
Stephen Burke
SVP, Human Resources
Brittany Ferdman
Purchasing Coordinator
Anastasia Khvorova
Co-founder
Craig Mello
Co-founder
Jeff Young
Chief Financial Officer
Serena Hung
Chief Medical Officer
Antonio N.
Sr. Director Information Technology
RJ
Rachael Johnson
Executive Assistant

Teams

+8

Scientific Research Team

11 members

+7

Scientific and Technical Advisory

10 members

+4

Leadership Team

7 members

+1

Operations Team

4 members

+2

Research and Development

5 members

Similar companies

Generate Biomedicines

3 followers

eGenesis

1 follower

School District of Philadelphia

4 followers

Bezos Academy

3 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

23andMe

81 followers

Thurgood Marshall College Fund

1 follower

Day One Biopharmaceuticals

1 follower

James Madison University

1 follower

QurAlis

1 follower

Explore companies